GRI Bio, Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRI Bio, Inc and other ETFs, options, and stocks.About GRI
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis.
GRI Key Statistics
Stock Snapshot
GRI Bio, Inc(GRI) stock is priced at $0.42, giving the company a market capitalization of 2.34M. It carries a P/E multiple of -0.03.
During the trading session on 2025-12-18, GRI Bio, Inc(GRI) shares reached a daily high of $0.48 and a low of $0.40. At a current price of $0.42, the stock is +6.2% higher than the low and still -12.3% under the high.
Trading activity shows a volume of 1.2M, compared to an average daily volume of 2.54M.
The stock's 52-week range extends from a low of $0.40 to a high of $15.64.
The stock's 52-week range extends from a low of $0.40 to a high of $15.64.
GRI News
Analyst Matthew Keller of H.C. Wainwright reiterated a Buy rating on GRI Bio, retaining the price target of $10.00. Claim 50% Off TipRanks Premium and Invest wi...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
GRI Bio, Inc. (NASDAQ:GRI) on Wednesday shared topline data from the Phase 2a GRI-0621-IPF-02 trial evaluating GRI-0621 for idiopathic pulmonary fibrosis. IPF...